Lung Cancer Screening and Approach to the Lung Nodule

Brigham and Women's Hospital

A. Ramaswamy

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

Lung Cancer Screening

Kyle Hogarth

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

Year in Review: Lung Cancer

Balazs Halmos

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Key to Successful Lung Cancer Screening and Lung Nodule Program

University of Colorado Department of Medicine

N. Thomas

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Metaphorical Signs in Computed Tomography of Chest

Atul C. Mehta

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

Approach to Screening and Nodule Surveillance Program

Weill Cornell Medicine Cardiothoracic Surgery

B. Pua

Lambert-Eaton Myasthenic Syndrome (LEMS) - Clinical Pearls

For-Shing Lui

Lung Cancer Screening in Primary Care

UNC Lineberger Comprehensive Cancer Center

N. Robertson

Updates in Small Cell Lung Carcinoma

Janakiraman Subramanian

The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC

COR2ED The Heart of Medical Education

U. Malapelle

The Role of Molecular Biomarkers for Lung Nodule Evaluation

Cleveland Clinic Respiratory Institute

P. J Mazzone

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO …

2024 ASCO® Annual Meeting Insights Hub

A. Chiang